SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011769
Filing Date
2018-08-14
Accepted
2018-08-14 16:01:43
Documents
53
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 559865
2 ex31-1.htm EX-31.1 11660
3 ex31-2.htm EX-31.2 11633
4 ex32-1.htm EX-32.1 6322
5 ex32-2.htm EX-32.2 7574
  Complete submission text file 0001493152-18-011769.txt   4259950

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE obmp-20180630.xml EX-101.INS 674343
7 XBRL SCHEMA FILE obmp-20180630.xsd EX-101.SCH 49093
8 XBRL CALCULATION FILE obmp-20180630_cal.xml EX-101.CAL 55678
9 XBRL DEFINITION FILE obmp-20180630_def.xml EX-101.DEF 202139
10 XBRL LABEL FILE obmp-20180630_lab.xml EX-101.LAB 380723
11 XBRL PRESENTATION FILE obmp-20180630_pre.xml EX-101.PRE 292458
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 181017216
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences